Careers  |  Sign In  |  Register  |   Twitter

New Class of Cancer Drug Shows Promise

An article in The New York Times reports that a new class of cancer drugs, capable of unleashing the immune system to attack cancer cells like it does to bacteria, has shown promising results in new tests this week. This new mechanism of fighting cancer cells “could be an alternative to often-debilitating chemotherapy.” Programmed death receptor-1 is a brake on the immune system and these drugs work to disable this receptor. Researchers explain that ”it might be harder for the tumor to become resistant to the immune system, which can adapt, than to a single drug.”

Read it in The New York Times.